press releases

Optune, a Tumor Treating Fields delivery system, provides a novel, non-invasive treatment for recurrent glioblastoma, the most common and deadly malignant primary brain cancer More than 270 clinical centers have been certified globally, primarily in the United States, Japan and Germany September 08, 2015… Read More

September 04, 2015 10:24 AM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure, a commercial stage oncology company, announced today that its ongoing and future clinical trial designs in lung cancer will be presented at the 16th World Conference on Lung Cancer (WCLC). The WCLC is the world’s largest… Read More

August 26, 2015 07:00 AM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure, a commercial stage oncology company, announced today that data describing the latest understanding of how Tumor Treating Fields (TTFields) distribute within tissues and cells will be presented at the 37th Annual International Conference of the Institute… Read More

World Economic Forum today announced its selection of the world’s 49 most promising Technology Pioneers 2015 The full list of recognized Technology Pioneers can be viewed here August 05, 2015 03:30 AM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure,… Read More

New website provides patients and their families with educational information regarding ongoing clinical trials testing Tumor Treating Fields in a variety of solid tumor cancers July 09, 2015 08:00 AM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure, a commercial stage oncology company, announced today the… Read More

Full dataset analysis confirms study met its endpoints, extending both progression-free and overall survival of newly diagnosed GBM patients Analysis will be presented on June 2, 2015 by Roger Stupp, MD at the 2015 Meeting of the American Society of Clinical Oncology in Chicago… Read More

Technology experts and cancer patient advocates will #HackGBM in Chicago this week May 28, 2015 03:59 PM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Novocure, a commercial stage oncology company, today kicks off Hack GBM: Finding Support Solutions for Glioblastoma Community Challenges, the first-ever hackathon to specifically… Read More

Optune, a Tumor Treating Fields delivery system, provides a novel, non-invasive treatment for recurrent glioblastoma, the most common malignant primary brain cancer Physicians at 23 brain cancer centers in Japan are now certified to provide Optune to recurrent glioblastoma patients on prescription order May… Read More

Presentation by Roger Stupp, MD will be the first report on the full 700 patient population that enrolled to the EF-14 trial in newly diagnosed glioblastoma 2015 ASCO Annual Meeting May 13, 2015 05:00 PM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure, a commercial stage… Read More